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Abstract: Food allergies are increasing at an alarming rate, with 6.5% of the general population
affected. It has been hypothesized that the increase in allergies stems from the “hygiene hypothesis”.
The gut microbiome, a collection of microbiota and their genetic contents from the gastrointestinal
tract, has been shown to play a part in the development of food allergies. The Food and Drug
Administration requires all regulated food companies to clearly state an inclusion of the major, or
“big eight” food allergens on packaging. This review is to provide information on the significant
advancements related to the gut microbiome and each of the eight major food allergies individually.
Establishment of causal connection between the microbiome and food allergies has uncovered novel
mechanisms. New strategies are discussed to prevent future sensitization and reaction through novel
treatments involving functional additives and dietary changes that target the microbiome.
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1. Introduction
A food allergy is defined as an abnormal immune reaction to the repeated exposure of certain
foods [1]. It can manifest as minor gastrointestinal distress and skin rashes, to life-threatening
anaphylactic shock [1]. These adverse symptoms and the burdens associated with avoiding food
products can disrupt quality of life. It is unknown why some individuals will develop an allergy to
a specific antigen, while others will not [2].
Food allergies have been rising at an alarming rate, nearing 6.5% (5% of adults and 8% of
children) of the general population (of developed counties) affected to date [1]. Of these food allergies,
90% are caused by “The Big Eight”, a term referring to all major Food and Drug Administration
(FDA)-regulated food products. These foods include cow milk, hen’s egg, fish, crustacean shellfish,
tree nut, peanut, wheat, and soybean [1]. It has been hypothesized that the increase in allergies stems
from the “hygiene hypothesis”, which states that early life exposure to microorganisms protect against
allergic disease [1]. The gut microbiome, termed a collection of microbiota and their genetic contents in
the gastrointestinal tract, has been shown to play a part in the development of asthma, atopic dermatitis,
and food allergies through mucosal tolerance and possible bacterial metabolites over the past decade.
Despite being a very timely and important topic, no recent reviews exist addressing the gut
microbiome and its relationship with allergens specific to each of The Big Eight foods. This review will
present the gut microbiological and dietetic factors associated with the development and treatment of
food allergies. Food antigens will be explored individually for their connection to the gut microbiome
(Figure 1).
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Figure 1. Summary of bacterial and dietary changes involved in food allergy. 
2. We Are What We Eat: Diet and the Microbiome 
Trillions of gut microbes from thousands of different species make up the highest density of 
microbes within the human body [3]. Diet shapes the configuration of the gut microbiome at early 
life. The gut microbiome of infants that were breastfed have a unique and beneficial composition that 
is not observed in those given formula when compared later in life [4]. Gut microbiome dysbiosis in 
early life is thought to be related to development of allergies later in life. When children start a solid 
food diet (at approximately 6 months), the gut microbiome shifts significantly for a second time. The 
adult gut microbiome generally can be classified into three distinct enterotypes that are dominated 
by Bacteroides, Prevotella, or Ruminococcus, respectively [4]. The diet of the individual influences the 
enterotypes, with Bacteroides being associated with a Western-type diet high in proteins and fat, and 
Prevotella being associated with plant fiber consumption. As a modifiable target, modulation of the 
gut microbiome through dietary intervention (high fiber-related diet), prebiotics or probiotics have 
seen an increase in both research interest and product development in recent years. However, the 
magnitude and duration of microbiome changes by dietary intervention have been largely 
inconsistent. 
High levels of fiber can increase the production of short-chain fatty acids (SCFAs) from specific 
bacteria in Firmicutes, such as Bacteroidetes, Clostridia (Ruminococcus enterotype) and Bacilli [5]. 
SCFAs are bacterial fermentation products and are profoundly affected by food intake. There are 
three common short-chain fatty acids that tend to be produced by bacteria: acetate, propionate, and 
butyrate. Acetate is the acid produced in the highest quantity, but butyrate is thought to be the main 
energy source for colonocytes. These acids are absorbed into the portal vein during lipid digestion, 
and have been associated with major health benefits, including a reduced risk of inflammatory 
diseases and Treg function [6,7]. A decrease in SCFAs may lead to an increase in pathogenic bacteria 
due to a decrease in gut pH [8]. Pathogenic bacteria can cause epithelial damage to the colon walls, 
and many believe food allergies are an epithelial barrier disease [9].  
Other metabolites derived from commensal bacteria include long-chain fatty acids (LCFAs), 
glycolipid, histamines, vitamin B2/B9 byproducts and amino acids [10,11]. LCFAs are major 
nutrients, including the clinically important ω3 and ω6 FAs, with ω3 FAs known to have anti-allergic 
and anti-inflammatory properties [10]. Pro-inflammatory LCFA metabolites, including stigma- and 
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anti-inflammatory properties [10]. Pro-inflammatory LCFA metabolites, including stigma- and
sitosterols and 8-hydoxyoctanoate, are associated with lower risk of allergy development [10].
These metabolites are thought to decrease IL-4 produced Th2 cells.
The current dietary interventions for those with food allergies include tolerance or simply
avoidance. The enrichment of SCFA-producing bacteria in the body has been investigated as a potential
treatment, as stated above, using the enrichment of the Firmicutes phylum. One may naturally increase
these bacteria by introducing higher levels of fiber, or prebiotics, into their diet. High-fiber diets used
in mice were found to decrease allergic sensitization [12]. Other options for dietary changes may
include an increase in food-derived probiotic bacteria found within fermented foods. Histamine can
be derived from bacterial and dietary sources, including fermented foods. It should be noted that
dietary and bacterial-derived histamine’s role in food allergy is still currently unknown. However,
some data suggest that the intestinal inflammation brought on from dietary histamine may enhance
sensitization [11]. Western lifestyle and diet promote a change in bacteria which has not been associated
with the human gut in evolution. These changes from a millennia of human biology, even small, may
lead to larger detrimental outcomes.
3. Just One Bite, or Maybe Two: The Mechanisms of Food Allergy
Certain food may cause non-immune responses in the body, including digestive enzyme disorders.
However, these should not be confused with true food allergies. Food allergies are atopic disorders in
which the body has a hypersensitive immune response to a normally harmless food-derived protein [2].
The most common cause of food allergy is defined as an immediate IgE-mediated reaction.
For an allergic reaction to occur, the antigen must interact with the intestinal mucosa multiple times.
One will not have an allergic reaction to a food the first time they ingest it. This process is defined as
sensitization. For food sensitization to occur, the protein must get to the intestinal epithelium without
denaturing. They are then transferred from the lumen into the mucosa through gut epithelial cells and
other specialized cells [13]. Once in the mucosa of the gut, mucosal dendritic cells interact with the
antigen and proceed to T cell locations to present the antigen to naive T cells, to form the classically seen
Th2 cells. Th2 cells will produce certain cytokines, including IL-3, IL-4, IL- 5, IL-9, and IL-13. From this,
B cells will proliferate to produce IgEs, in place of other antibodies like IgG or IgM. These IgEs have
a high affinity for FcεRI receptors found on mast cells and basophils and gear the cells up for further
exposure, as sensitization is now complete [2]. The processes of sensitization can occur in several other
locations in the human body, including the oral cavity, skin, and respiratory tract [13].
When there is reintroduction of the antigen, anaphylactic degranulation of the mast cells and
basophils follows and there is a release of inflammatory mediators, including histamine, cytokines,
and leukotrienes. At this point, the presence of the food antigen in any body tissue (mouth, stomach,
gut) can induce an IgE-mediated reaction that generally occurs a few minutes after exposure.
Those with IgE-mediated or mixed food allergies can be identified based on the detection of food
allergen-specific IgE.
Other forms of food allergy include delayed non-IgE-mediated reactions and pollen food
syndrome (PFS), which are less common and often confused for IgE-mediated food allergies [2,14].
Delayed non-IgE-mediated food allergies involve antigen contact with sensitized T lymphocytes,
as opposed to mast cells, which then damage the gut mucosa. This type of reaction is associated
with disorders such as celiac disease and may occur hours later, involving vomiting and diarrhea [2].
Interestingly, pollen food syndrome is still an (IgE)-mediated disease. However, it is a consequence of
an already established pollen allergy cross reacting with antigens, similarly structured to pollen, found
within certain foods [14]. This is commonly seen in nuts, fruits, and vegetables. However, both are not
within the scope of this review.
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4. “Good Source of Protein?”: Interactions of Food Matrices and Gut Permeability
Allergy type and dosage can affect immune response, along with adjuvants in the gut. The more
food protein that makes it intact to the gut, the more chance there is of sensitization. While most are
broken down by gastric acid and digestive enzymes, some intact proteins and peptides can move
further into the large intestine. Certain factors can affect sensitization by allowing for a strong or
weaker epithelial wall; including genetics, alcohol, anti-inflammatory drugs, pathogens, and stress [2].
Gut bacterial populations and bacteria-derived proteases and peptidases may affect protein absorption
into the blood stream [15]. Cooking promotes protein denaturation through various forms of heat
processing (pasteurization, blanching, convection/conduction). However, peanuts and tree nuts are
commonly roasted and many of their allergic proteins are not broken down in the process [16]. It is
also believed that the heating of peanuts and shrimp may enhance allergenicity, by aggregating protein
to be more resistant during digestion [17].
Along with this, a few of The Big Eight food allergens can be consumed uncooked in some cases.
Soybeans, finfish, and shellfish are commonly eaten raw. These uncooked or harder-to digest-factors,
along with a higher protein content, may contribute to why these foods are considered to cause more
sensation in individuals than other foods. Interestingly, many children may tolerate baked milk and
egg if given in a wheat matrix, as other ingredients eaten together are known to decrease the proteins
availability to interact with the epithelial wall [17].
It is currently unclear why these food proteins cause a negative immune response in
some. The gut-associated lymphoid tissues maintain tolerance by differentiating against self or
non-self-antigens and through the recognition the pathogens [18]. However, if this process breaks
down, the body can no longer tell the different between friend or foe. Tolerance can be achieved to
negate harmful effects. Oral tolerance to a food allergen can develop after frequent expose to the antigen
due to possible changes and mechanisms involved in the dendritic cells, gut epithelial cells, and the
gut microbiome. However, at this time, the exact mechanisms of desensitization is unknown [13].
5. The Gut, The Big Eight and the Correlation between the Two
These is a clear difference between each food allergy, both in sensitization period and severity of
reaction. Children tend to outgrow cow milk and hen’s egg allergies, but peanut and shellfish allergies
can occur later in life and may be very severe. Table 1 displays the different food proteins that have
been found to induce allergic reactions.
Table 1. Proteins present in The Big Eight foods known to induce allergy.
Cow milk Casein, whey, bovine serum albumin, immunoglobulin G heavy chain anda-lactalbumin [19]
Hen’s egg Whites: Ovomucoid, ovalbumin, ovotransferring, and lysosome [20]Yolk: Livetin, vitellenin and apoprotein B [20]
Peanut Cupin(Ara h 1, 3), prolamin(Ara h 2, 6, 7, 9), profilin(Ara h 5), bet v-1-relatedproteins(Ara h 8), oleosin(Ara h 10,11) and defensin(Ara h 12, 13) [21]
Tree nut Vicilin, 2S albumin, nsLTP, legumin, bet v 1-like, oleosin, 60 s acidic ribosomal prot.P2, manganese superoxide dismutase and profiling [22]
Shellfish Tropomyosin, arginine kinase, myosin light chain, and sarcoplasmic calcium-bindingprotein [23]
Finfish Parvalbumins, enolase, aldolase, tropomyosin, vitellogenin [24]
Soy
Hull proteins, kunitz trypsin inhibitor, glycinin, α-subunit of β-con-glycinin, and 50-kd
protein with homology to chlorophyll A-B binding protein and starvation-associated
message [25]
Wheat α-Amylase/trypsin inhibitor, album, globulins, serine proteinase inhibitor, lipid proteintransfer, thioredoxin, peroxidase, gliadin, thiol reductase, and thaumatin-like protein [26]
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5.1. Cow Milk
Often confused with lactose intolerance, a cow milk allergy (CMA) can be a reaction to the main
two proteins in milk, casein, and whey (Table 1). This allergy affects 2–6% of children, making it the
most common childhood food allergy [27]. The typical onset age for milk allergy is 4.3 months into
life, or when exposed to milk after breast feeding [28]. Most children become tolerant by the age of
three, but some do not show resolution until teenage years [29]. Milk allergies can leave children with
a challenge of getting proper nutrition. Infant formula typically comprises a blend of cow milk whey
and casein, vegetable fat, lactose sources, vitamin/mineral mix, and probiotic bacteria [30]. Because of
the use of cow milk protein in these typical formulations, a substitute is required. Formula is used
widely, as only 38% of newborns exclusively breastfed globally. In the United States, only 75% of infants
are exclusively breastfed starting from birth, with 67% of all children relying on infant formula for some
portion of their nutrition after three months. Only 13% of new mothers meet the recommendation of
breastfeeding exclusively for six months [30]. Exclusive breastfeeding has been linked to a reduction in
specifically cow milk sensitization. However, it should be noted that many different studies have been
carried out, with conflicting results between breastfeeding, formula feeding, and milk allergy [31,32].
The exact mechanism as to why certain children will develop CMA remains poorly understood [33].
Increasing evidence suggests that a normal gut microbiome is critical to suppress CMA. Studies have
shown germ-free animals to be at a higher risk for sensitization to cow milk protein [34–37]. Maternal and
infant use of antibiotics has been associated with an increased risk of the child developing a CMA [38].
In addition, compositions of the early life gut microbiome differ between CMA resolution and continuing
allergy in children, with enrichment of Clostridia and Firmicutes in the infant gut microbiome of those
whose CMA resolved [39]. In a study of 226 children, little over half (56%) had the allergy resolved,
with the gut microbiome composition between the two groups being significantly different between 3
and 6 months. This was not seen between other ages, supporting the importance of the early life gut
microbiome in CMA resolution.
There are two different theories involving the Clostridia class from Firmicute phylum and
its involvement in milk allergy. One theory states Firmicutes and those in the Clostridia class are
beneficial, but others claim they may be harmful. Bacteria from Clostridia are major butyrate producers.
Butyrate is known to regulate colonic regulatory T cells that are essential for immune tolerance [40,41].
Butyrate also allows for regulation of the intestinal epithelial barrier which may decrease the intake
of food antigens into the blood. Lower abundance of the Firmicutes phylum and the Clostridia class
has been seen in children whose allergy did not resolve [39]. However, it is theorized that not all
Firmicutes and products of the Clostridiales species lead to protection, but only specific species
and even strains. In one study, treatment with extensively hydrolyzed casein formula combined
with Lactobacillus rhamnosus GG leads to an increase in Firmicutes, including Roseburia, Blautia and
Coprococcus (all from the Clostridiales order), in both allergic and healthy groups [42]. Oscillospira was
only seen in those whose allergies resolved. In their analysis of fecal butyrate levels, higher levels
were found in those who became tolerant to milk allergies. Interestingly, there were strain-specific
differences of Blautia and Roseburia between the tolerant and allergic patients. It should be noted that
this study was conducted on stool after allergic symptoms start to appear, and that the importance
of an increased abundance of Firmicutes may be during sensitization. The gut microbiome develops
in early life and becomes mature at 2–3 years old [4]. Longitudinal characterization of the microbial
dynamics before and after sensitization and challenging will provide a holistic view of the evolving
microbiome and development of CMA. Another Clostridia species, Anaerostipes caccae, has been
shown to reduce the risk of developing CMA [43]. When using a fecal microbiota transplantation
(FMT) from CMA children into mice, the mice became more susceptible to anaphylactic reactions to
milk protein when compared to mice treated with healthy children’s stool, in which higher levels of
Clostridiales and Anaerostipes caccae were found. Gene expression analysis of intestinal epithelial cells
of recipient mice identified genes involved in pyruvate metabolism, acot12 and me1, were upregulated
in the ileum of CMA-colonized mice, compared to the healthy-colonized mice. An integrated analysis
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identified a strong negative correlation of Anaerostipes caccae with pyruvate metabolism. The latter
was speculated to be one key intermediate during glycolysis, a metabolic pathway for colonocytes
during gut microbiome dysbiosis. This study highlights that host-microbiome interaction is central to
regulating tolerance to dietary antigens.
The counterargument for the beneficial effects suggests that the higher concentration of butyric
acid produced by bacteria in the Firmicutes phylum can increase the permeability of intestinal
mucosa, thus possibly allowing higher amounts of cow milk protein to enter the bloodstream [39,44].
A metagenome functional prediction conducted on the stool of allergic children found a decrease in
fatty acid metabolism in children whose allergy resolved [39]. It was suggested that cow milk lipids
drive proinflammatory effects, and a decrease in fatty acid metabolism may be positively correlated
with less inflammation. Other studies have found lower levels of branched short-chain fatty acids
in healthy infants compared to allergic infants [45]. This study also found high levels of Clostridium
coccoides in those with a cow milk allergy, along with an increase in butyric acid. Other studies have also
found increased levels of Clostridium coccoides in groups which did not develop tolerance to CMA [46].
However, as stated above, it is important to remember that it is possible not all Firmicutes may lead to
protection, even being as specific as species and strains.
Introduction of bacteria that are suppressive of CMA has long been proposed to both preventing
sensitization or aiding immunotherapy. Lower counts of probiotic bacteria, Bifidobacteria and Lactobacilli,
have been reported in the guts of children with CMA [28]. The clinical outcome by reintroduction
of these bacteria is mixed. Lactobacillus casei CRL431 and Bifidobacterium lactis Bb-12 were given to
infants diagnosed with CMA for 12 months [29]. However, it was found that these bacteria did not
have any effect on the acceleration of milk allergy tolerance. Comparatively, a similar study was
conducted, which looked at the most common probiotic on the market, Lactobacillus rhamnosus GG
and its ability to accelerates tolerance acquisition in infants with cow milk allergy [47], as L. rhamnosus
GG has been shown to promote respiratory and gut immunity [48,49]. After 6 months of Lactobacillus
rhamnosus GG supplementation, 60% of the infants with CMA had resolved symptoms, compared to
the 22% in the control group. It was hypothesized that the resolution of CMA could be related to
the immunoregulatory role of the Lactobacillus rhamnosus GG. Lactobacillus rhamnosus GG is found
to balance generation of Th2-related cytokines [47]. With a more in-depth analysis of Lactobacillus
rhamnosus GG, the probiotic was found to increase specific butyric acid-producing bacteria in the gut of
children whose allergies resolved after treatment [42].
Bifidobacterium is another common probiotic used outside of the Lactobacillaceae family and is
commonly found in the gut of infants. An increase in these bacteria has been seen to improve the
characteristics in other IgE or Th2 allergies [50,51]. Bifidobacterium breve M-16V and a supplement
containing a mixture of short-chain galacto-oligosaccharides and long-chain fructo-oligosaccharides,
was introduced into the mice’s diet and the anaphylactic reaction to milk protein was measured [52].
A combination of both was found to reduce ear swelling upon cow milk protein introduction in
the mice, with less effectiveness when used separately. The protective effect of Bifidobacterium in the
mouse model of food allergy is also evident in another study where serum IgE levels were lower after
administration of B. infantis CGMCC313-2, compared to that in controls [53]. A well-characterized
healthy infant microbiota, containing high levels of Bifidobacterium and Bacteroides, was transplanted it
into germ-free mice, which lead to an improved protection of milk allergy [36].
Unpasteurized milk is thought to protect from asthma and food allergy. However, its benefits are
controversial [54]. Unpasteurized milk is known to contain many bacteria, including probiotics,
which are otherwise inactivated in pasteurized milk. This includes lactic acid bacteria such,
as Lactobacillus, Streptococcus, Enterococcus, Lactococcus, Leuconostoc, Weisella and Pediococcus [55].
However, possible contamination with numerous pathogenic bacteria, including Staphylococcus aureus,
Salmonella enterica, and Escherichia coli, may lead to further gut damage [56]. Individuals should look
for safer sources of probiotics, including other dairy products such as yogurts and cheese.
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5.2. Hen’s Egg
Egg allergies affect 0.5% to 2.5% of young children, starting around infancy. However, this is
as high as 8.9% of infants in certain populations [20], making it the second most common food
allergen in children. In addition to causing dietary restrictions, egg allergies have significant health
consequences for children, as they cannot receive certain vaccines generated using eggs. Ovomucoid is
considered the main allergen in egg because of its immunoreactivity and heat resistance (Table 1).
While ovalbumin (OVA) is the most abundant potential allergen in eggs, it is easily denatured
during thermal processing [20]. Although most proteins are found within the egg whites, allergic
children should avoid eggs altogether, as proteins can bleed into the yolk, along with the yolk having
small amounts of allergic proteins themselves [57]. Tolerance may be accelerated similarly to milk,
with studies finding some children able to tolerate eggs faster after a diet including baked eggs [58].
Early life gut microbiome composition of those with egg allergies has been shown to play
an important role in development of the disease [59]. However, like the aforementioned milk studies,
no association has been found between the gut microbiota and egg allergy resolution later in life (by the
age of 8 years). Higher microbial diversity during this early stage of life has been found to correlate
with egg allergy, sharing similar results to previous studies on other allergic diseases [59]. At the
phylum level, Firmicutes and Verrucomicrobia are higher in infants with egg allergy, with Ruminococcus
and Lactococcus associated on a genus level, when compared to health patients [59]. A difference in
purine metabolism was also observed, with less in those with egg allergy. A depletion of uric acid
inhibits the activity of xanthine oxidase in purine metabolism, significantly changing the inflammatory
responses of mice. This has been seen in asthma exacerbation, a mechanism proposed to be involved
in sensitization [60].
Bacterial interventions are a common research topic to alleviate egg allergy. Oral administration
of Bifidobacterium bifidum, Lactobacillus casei, and Escherichia coli were found to lower IgE, or overall
immune response in OVA with cholera toxin mice [61]; however, E. coli caused an unhealthy lack
of weight gain. The differences in OVA-specific fecal IgA levels and OVA-specific serum IgG1 levels
among the experimental bacteria suggest that they are likely to inhibit allergy responses through
different mechanisms. Bifidobacterium longum, but not Enterococcus faecalis, extracellular vesicle–derived
proteins were found to suppress egg allergies by induced apoptosis to bonded mast cells in mice [62].
The effect of other bacteria, that are not lactic acid bacteria, has also been investigated
in the egg allergy mouse model to explore possible benefits [63]. Therapy with Clostridiales,
Subdoligranulum variabile and a Bacteroidales consortium has been found to suppress allergy. In this
study, a MyD88/ROR-γt pathway in nascent Treg cells was deficient in food allergy infants and mice.
Inhibition of this pathway in Tregs abrogated protection. Oral supplements with 17 Clostridia strains,
previously isolated and invested for positive effects, led to a reduction in OVA-specific IgE after
sensitization and reduced diarrhea scores after challenge in mice [64].
OVA-sensitized mice with a mutation in the IL-4 receptor α chain (Il4raF709) harbor a distinct
gut microbiome, with over-represented populations of Lachnospiraceae, Lactobacillaceae, Rikenellaceae,
and Porphyromonadaceae [6]. Fecal transplantation of the microbiome in OVA-sensitized Il4raF709 mice
promoted OVA-specific IgE responses and anaphylaxis. Interestingly, treatment with OVA-specific Treg
cells led to a suppression of allergic response, accompanied by the suppression of allergy associated
microbes. Taken together, these reports suggest that specific gut microbiota and their associated
immune effects are at least partially responsible for OVA-mediated food allergy, providing additional
rationale for microbiome-based intervention in food allergy.
5.3. Peanut
Peanut allergies are one of the most predominant food allergies to carry into adult life [65]. At least
11 peanut antigens have been described (Table 1). The quality of life for a child with a peanut allergy
has been perceived to be worse than a diabetic child [66]. Peanuts can be easily hidden in foods,
including their use as bulking agents in non-related items. Accidental exposure is common in children
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with peanut allergies, with annual incidence of 12–15% in these children [67]. There has been an increase
in peanut allergies, with a 21% increase since 2010, with 2.5% of children in the U.S. having a peanut
allergy [68]. Because of this and the severity of the reaction, peanut oral immunotherapy interventions
have been developed [69]. More recently in 2020, the FDA has approved the first immunotherapy
treatment, termed “Palforzia” (125,696) [70]. Oral immunotherapy can be described as an introduction
of peanuts to children at a young age that show signs of peanut sensitization in hopes of increasing the
threshold that induces a reaction.
While Palforzia does not contain a bacterial component, many studies have included bacteria
as an adjunct for the therapy. The first randomized placebo-controlled trial on the effectiveness of
a combination of Lactobacillus rhamnosus GG and peanut oral immunotherapy lead to 89.7% of those
who received treatment to be desensitized, compared to 7.1% in the no bacterial control group [71].
Lactobacillus rhamnosus GG was used in a different peanut oral immunotherapy, with 67% of the
children in the treatment group and 4% in the placebo desensitized following the end of the trial [72].
It has been proposed Lactobacillus promotes peanut tolerance by enhancing the tolerogenic effects of
cells, including regulation of T cells. Other treatments that have been investigated include FMT and
a rationally defined bacterial consortium supplement. A Boston Children’s Hospital treatment in which
children are given oral encapsulated frozen fecal microbiota transplantations (NCT02960074) [73] is
set for completion in late 2020. Vedanta Biosciences has recently enrolled their first peanut allergy
patient to receive VE416, an orally administered live biotherapeutic product containing a defined
bacterial consortium. This is thought to have similar, if not more benefits than a FMT, without the need
for inconsistencies in a live donor (NCT03936998) [74]. However, the potential impact of these new
treatments remains to be seen.
Dietary interventions have also been reported to have beneficial effects for peanut allergy.
The introduction of a high-fiber diet, with vitamin A, in mice improved oral tolerance and protected
against peanut allergy [12]. With only fiber and vitamin A, and not an added bacterial component,
the gut microbial ecology of the mice was reshaped to have more diversity and an increase in Firmicutes,
specifically Bacilli. In turn, this caused an increase in levels of acetate and butyrate. The direct feeding
of acetate and butyrate in drinking water was also found to protect mice from peanut sensitization.
This diet lead to an increase in tolerogenic CD103+ dendritic cells, which are required for oral
tolerance to antigens, and higher IgA serum levels. Specifically, this IgA increase is thought to be
associated with Clostridia. Mice treated with antibiotics or germ-free mice have been reported to be
more susceptible to peanut sensitization [75]. Reintroduction of Clostridia bacteria, but not Bacteroides
bacteria, blocks sensitization to peanut allergen in germ free mice [75]. The presence of Clostridia
was thought to be associated with an adaptive expansion of Tregs found in the intestine and induce
immunoglobulin class switching from IgE to IgA. It is believed that IgA contributes to the immune
response by reducing allergen uptake [76]. Elevated levels of uric acid have been found in mice
which have undergone sensitization to peanuts, as well as with children confirmed to have a peanut
allergy [77]. Uric acid is a byproduct of purine metabolism, and the depletion of uric acid during
sensitization of mice is known to prevent the development of IgE and IgG1. Changes in total antibody
composition may help prevent sensitization.
5.4. Tree Nuts
Tree nuts are a broad term used to describe any nut that grows on a tree, including almonds,
brazil nuts, cashew nuts, hazelnuts, macadamia nuts, pecans, pistachios, and walnuts [22]. They differ
from peanuts, which are classified as legumes along with peas and soybeans. Consumption of walnuts
and other tree nuts has been seen to increase healthy probiotic and butyric acid-producing bacteria
in the gut [78]. Approximately 4.9% of the general population has a tree nut allergy. The lack of
this food source can have potential negative effects on health, including a lack of vegetable protein,
dietary fiber, magnesium, potassium, copper, and vitamins E and K [22,79]. Peanut and tree nut
allergies overlap within people commonly, as the structure between the antigenic proteins in both are
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similar. Unsurprisingly, a meta-analysis has found a stronger correlation between peanut and tree nut
allergies [80]. Along with this, many nut allergies are due to an allergic reaction to pollen and not to the
nut protein itself. This phenomenon is referenced to as pollen food allergy syndrome [81]. There are
several different tree nut proteins that can cause allergy, most being found within the metabolic and
storage protein family of the nut (Table 1) [81].
For those with tree nut allergies, a decrease in Clostridiales and higher Bacteroidales has been
observed [80]. With peanuts and tree nuts taken together, a positive association can be seen in allergy
with Bacteroides, Bacteroides fragilis and Bacteroidales, and a negative association with Clostridiales,
Prevotella and Ruminococcaceae [80]. There is currently no microbiome associated treatments for tree
nut allergies. However, like peanuts, there are serval immunotherapy options which have been
studied [82,83]. As peanut and tree nut allergies are shown to have a similar structure between allergic
proteins, positive results from bacterial tree nut immunotherapies may occur as it has with peanuts.
Similarly, future work on utilizing certain bacteria as adjuncts to treatment for tree nut allergies should
be investigated.
5.5. Crustacean and Molluscan Shellfish
Crustaceans are a subsection of the phylum Arthropoda and include crab, rock lobster, prawn,
and shrimp. Mollusks generally consumed include gastropods (snail), bivalves (clam, oyster, scallop and
mussel), and cephalopods (squid and octopus) [23], and belong to the phylum Mollusca. Tropomyosin
is the predominant allergic protein in crustacean, while mollusks contain less well-understood allergens,
along with different tropomyosin (Table 1). Mollusk allergies are known to cross react with other
shellfish allergies regardless of these differences; however, crustacean and molluscan allergens do not
cross react with fish allergens [23]. Recent studies have shown tropomyosins from house dust mites to
also cause allergies in those allergic to shellfish trompmyosins [84]. However, vertebrate tropomyosins
are not known to cause disease. As of 2019, crustacean and molluscan allergy is the most common food
allergy affecting adults in the United States [85]. Importantly, while most of The Big Eight allergies
develop in childhood, shellfish allergies can develop at any point in life, much like peanuts [86].
Bifidobacterium has been investigated to have a role in the protection of shellfish-related food
allergy. Bifidobacterium infantis and Bifidobacterium lactis, bacteria commonly found in nursing mothers
and the guts of infants, was found to reduce shellfish-specific IgE in mice [87,88]. Bifidobacterium infantis
was found to revert bacterial proportion imbalance caused from the allergen, by increasing Dorea
and decreasing Ralstonia. It was proposed that this proportion of Dorea/Ralstonia is involved in Treg
cell differentiation and could help balance the Th2/Treg ratio. Bifidobacterium lactis was found to
increase the ratio of Treg and Th17 cells in a mouse model. Other studies have found Bifidobacterium
longum and Bacillus coagulans to regulate gut dysbiosis and mitigate overactive Th2 response in
tropomyosin-induced allergic mice [89]. Bifidobacterium longum and Bacillus coagulans have also found
to regulate gut arginine metabolism pathways, leading to the conclusion that metabolites of aspartate
and arginine may be critical for prevention of food allergy. However, it should be noted that these
studies mostly focused on Bifidobacterium, and the effects of other bacteria has not been as well
investigated. Future work should focus on investigating the role of other commensal bacteria in
mitigating shellfish allergies.
5.6. Wheat
Gluten sensitivity is not a true wheat allergy. However, the insoluble gluten proteins gliadins
and glutenins are reported to be the most responsible for inducing IgE-related sensitization,
especially omega-5-gliadin (Table 1) [26]. Celiac disease is a common non-IgE-mediated reaction
involving intolerance to gluten. The prevalence of wheat allergies varies between different regions of
the world, ranging from 0.2% to 1% [26]. Like cow milk and egg allergies, wheat allergy is commonly
outgrown by adulthood [65]. Those with wheat allergies miss out on major fiber sources, like whole
grains and bran [90]. Many of these fibers are considered “prebiotic” and promote the growth of
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health gut bacteria [90]. Not surprisingly, it has been seen that the loss in fiber significantly reduces
the abundance of fiber-degrading bacteria, resulting in a reduction in SCFA levels [91]. Luckily,
within resent years, there has been in increase in wheat free, or gluten free, products in the food
industry [92]. While these products have been made for gluten intolerance in mind, those with
an IgE-mediated wheat allergy or gluten sensitivity may also benefit. There are currently no data on
the interactions of the microbiome with wheat allergies. This may be of great interest, due to the large
fiber components of many wheat products.
5.7. Soy
Soy is a complete protein, with sensitization normally occurring from the soybean hull proteins
(Table 1) [25]. A total of 0.4% of children in the U.S. have a soy allergy, and 50% of those tend to outgrow
it by adulthood [93]. Interestingly, one report found that eighty-eight percent of those with soy allergies
also have peanut allergies [93]. Soy lecithin is a very common additive included in many food items.
For instance, it is used as an emulsifier in chocolate and dairy products and filler in baked goods to
reduce fat content. Unfortunately, not much work has been completed on the effect of avoiding soy
consumption on the gut microbiome, nor has there been any research on the potential role of the gut
microbiome in soy allergy.
5.8. Finfish
The consumption of fish is beneficial, as fish are high in omega-3 and omega-6 fatty acids. Omega-3
is well known to have many health benefits and has been seen to help with other IgE-mediated
conditions [94]. Fish oil tablets may be taken, but many of these capsules are heavily oxidized
before reaching the consumer. Finfish allergens, as with shellfish, may not appear until adulthood.
However, this may be due to a lack of fish in childhood diets. The main proteins that cause allergy
are parvalbumins, with different variations found as the main protein in different fish (Table 1) [24].
Interestingly, previous studies have found that antacids encourage sensitization to parvalbumin in
mouse models [95]. This is likely due to the increasing the pH in the stomach, allowing the intact
protein to move along into the gut. As with wheat and soy, there is no previous research on the
interactions of finish allergy and the microbiome.
5.9. Common or Unique—Summary of Work
Shown below in Table 2 is a summary of the work presented in this review. There are currently
no studies of the role or interactions of the gut microbiome with wheat, soy, or fish allergies. It is
possible that some of the microbiome changes and allergy mechanisms may overlap between these
allergies and those described above. It is not uncommon for individuals to have multiple food allergies.
It is also interesting to note the possible change multiple allergies may have on microbiome dysbiosis
vs. a singular allergy; however, this has not been investigated. Therapies and supplements (Table 2)
may be utilized as functional food additives.
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Table 2. Summary of trends thought to promote/reduce risk or treat allergies for each of The Big Eight.
Promote Risk Reduce Risk Therapies and Supplements
Cow milk
d General antibiotic use before
and during pregnancy h [38]
a Increase in diversity h [39]
a,b Bifidobacterium infantis CGMCC313-2,
5 × 1010 CFU/mL for 6 days m [53]
d Short-chain fatty acid m [3] a Breastfeeding h [32]
c Lactobacillus rhamnosus GG,
4.5 × 107–8.5 × 107 CFU/g of formula
for 6 months h [42]
e Clostridium coccoides h [45] a,e Firmicutes h,m [39,42,43]
c Lactobacillus rhamnosus GG,
1.4 × 107 CFU/100 mL of formula for
6–12 months [47]
e Atopobium h [45] a,e Clostridia h,m [39,42,43]
e Lachnospiraceae h [42] e Oscillospira h [42]
a Bifidobacterium breve M-16V,
2 × 109 colony forming unit (CFU)/g for
7 weeks m [52]
e Ruminococcaceae h [42] e Roseburia h [42]
e Lactobacilli h [4] e Blautia h [42]
a Anaerostipes caccae h,m [43] a,e Bacteroides h,m [36]
a,e Bifidobacterium h,m [28,36] e Enterobacteria h [4]
Hen’s egg e Increase in diversity h [59] e Leuconostocaceae h [59]
a Bifidobacterium longum, 5 × 109 CFU
daily for 36 days m [62]
e Lachnospiraceae h [6,59]
a Clostridiales consortium, 5 × 107 CFU
twice weekly for five weeks m [63]
e Streptococcaceae h [59]
a Subdoligranulum variabile,
2.4 × 106 CFU twice weekly for
five weeks m [63]
e Lactobacillaceae m [6]
a Bacteroidales consortium 5 × 107 CFU
twice weekly for five weeks m [63]
e Rikenellaceae m [6]
a Bifidobacterium bifidum,
0.2% lyophilized for 8 weeks m [61]
e Porphyromonadaceae m [6]
a Lactobacillus casei, lyophilized for
8 weeks m [61]
d Proteobacteria consortium m [63]
a Escherichia coli lyophilized for
8 weeks m [61]
e Ruminococcaceae h [59] a Clostridia via monocolonization m [64]
Peanut
c Lactobacillus rhamnosus and peanut
oral immunotherapy, 2 × 1010 CFU once
daily with peanut protein for
18 months h [71]
c Lactobacillus rhamnosus GG and peanut
oral immunotherapy, 2 × 1010 CFU of L
rhamnosus CGMCC 1.3724 and 2 g of
peanut protein once daily for
18 months h [72]
a High-fiber diet and vitamin A for
2 weeks m [12]
a Direct feeding of acetate and butyrate
for 3 weeks m [12]
a Clostridia via 2 oral gavages,
once a week m [75]
Tree nuts e Bacteroidales h [80] e Clostridiales h [80]
e Bacteroides fragilis h [80] e Prevotella h [80]
e Bacteroidales h [80] e Ruminococcaceae h [80]
Shellfish e Ralstonia m [87] e Dorea m [87]
a,b Bifidobacterium infantis, 107 CFU/mL
for 20 days m [87]
b Bifidobacterium lactis, 10 mL
(1 × 106/mL) daily for 3 months h [88]
a Bifidobacterium longum, 2 × 1010 CFU
for 22 days m [89]
a Bacillus coagulans 2 × 1010 CFU for
22 days m [89]
Finfish
Wheat No data present
Soy
a Prevention of sensitization. b Therapeutic during allergic reaction. c Increased oral tolerance. d Worsened
Sensitization. e Bacteria found in the gut of either FA or health individuals. Mouse study m. Human study h.
Colony forming unit (CFU).
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Many of the same mechanisms were proposed for each of The Big Eight, with some contradicting
each other (Table 3). Many of the theories revolve around Clostridia and its abilities to regulate T cells.
Due to its importance as the most prevalent childhood allergen, cow milk has been the most studied
food allergen in term of microbiome association. Mechanistic differences between other allergens may
occur, as currently there are not enough data to defer the theory. Importantly, there are currently no
data available showing the effect that the gut microbiome has on wheat, soy, and finfish allergies.
Table 3. Summary of proposed mechanistic actions of the effect that the gut microbiome has on
food allergies.
Proposed Mechanisms Allergens Involved
Increase in diversity strengthens and stablishes immune system. h [39] Cow milk
Exclusive breastfeeding prevents the introduction of cow milk required for
sensitization. h [32] Cow milk
Firmicutes, those in the Clostridia order and those which increased butyrate
production, which regulate colonic regulatory T cells. mh [12,39,42,43,63,64] Cow milk, Hen’s egg
Those in the Clostridia order regulate innate lymphoid cell function to alter
epithelial permeability and reduce allergen uptake into the systemic
circulation. m [75]
Cow milk
Pyruvate metabolism from those in the Clostridia order and Leuconostocaceae
family depletes uric acid, which inhibits the activity of xanthine
oxidase. mh [43,59,75]
Cow milk, Hen’s egg
Bifidobacterium and Bacteroides invoke foxp3 gene activation, which is responsible
for the development and function of regulatory T cells. mh [28,36,52,53] Cow milk
B. infantis increased the abundance of butyrate-producing bacteria, which in
turn suppress the inflammatory responses triggered by Th2 cytokines. m [53,96] Shellfish
Lactobacillus rhamnosus GG promotes growth of short-chain fatty
acid-producing bacteria. h [42] Cow milk, Peanut
Bifidobacterium longum induces apoptosis to bonded mast cells. m [62] Hen’s egg
Antibiotics decrease level of beneficial bacteria. h [38] Cow milk
Firmicutes and those in the Clostridia order increased butyrate production,
which in turn increases the permeability of the intestinal mucosa. mh [28,44] Cow milk
Bifidobacterium longum and Bacillus coagulans regulate gut arginine metabolism
pathways and the metabolites of aspartate and arginine may be critical for
prevention of food allergy. m [89]
Shellfish
Mouse study m. Human study h.
6. There Is More Than Meets the Gut: Gaps and Future Perspectives
6.1. Viral and Fungal Interactions
While not given the same amount of attention as the bacterial world in the gut, viruses and
fungi may assist in the development and/or treatment of food allergy. Asthma, hay fever, and peanut
allergy were found inversely related to hepatitis A, herpes simplex virus 1, and Toxoplasma gondii
infections [97]. Previous research has shown murine norovirus may drive allergic disease, using egg
ovalbumin, through changes in normal dendritic cell function [98]. Interestingly, Kernbauer et al.
found murine norovirus infection of germ-free mice can replace the beneficial effects of commensal
bacteria [99]. Infection of murine norovirus 4 in non-obese diabetic mice was reported to lead to
positive changes in mucosal immunity, altering Tuft cell makers, cytokine secretion and mucosal
antibodies [100]. However, others have opposite conclusions, reporting that norovirus and rotavirus
infection may lead to increased protein absorption and sensitization in the gut [101]. Diets of varying
fiber and fat have been shown to change the virome. However, it is not well understood how these
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changes affect the human body [102]. While dietary fungi have been known to cause allergic reactions,
commensal fungi have not been studied for a possible cause or adjunct of disease. Allergy research
must be conducted on these missing areas, as major parts of the human microbiome include viral and
fungal organisms.
6.2. Clostridiales Cocktail
Next-generation probiotics is a term used to describe the use of commensal bacteria, rather than
lactic acid food associated bacteria, as probiotics [103]. There is a clear trend with the involvement
of the Firmicutes phylum, and more so with the Clostridiales order, involved in the sensitization
and treatment of food allergies. Clostridiales use as a therapy and a next-generation probiotic should
be further investigated. Throughout this review, Clostridiales has been mentioned several times in
multiple food allergens to be a beneficial bacteria. A strain-specific difference in beneficial effects in
Roseburia and Blautia give further evidence to the theory that not all Firmicutes, or SCFA-producing
bacteria, have the same effect on the body [42]. Dorea is discussed through multiple studies for possible
beneficial effects. For example, one study characterized 17 different Clostridia strains to have positive
health effects on food allergy [64]. Further investigation of the effects of Clostridiales on food allergies
and use as a treatment option would be valuable, especially regarding specific species, dosage, and
timing of administration.
6.3. Exparimental Design and Analysis
Most microbiome studies utilize the 16S ribosomal RNA (rRNA) sequencing technique. However,
only certain levels of taxonomy can be reached, with many only going down to the genus level. Virus and
fungal communities are completely missed. As stated above, species- and strain-level differences likely
contribute a larger part of allergy disease than previously discovered. Rarely functional characteristics
of bacteria are further explored as well, with many reports simply stating the taxonomical results from
sequencing. With most gut microbiome studies, and those discussed in this review, only the large
intestinal microbiome is analyzed, as stool is used for sampling. However, with food being digested in
the small intestinal, it is important to observe microbial and metabolic changes in this region as well.
These important research details are required to further understand the complexly of the immune
system and the entire microbiome.
7. Conclusions
Food allergies have an enormous impact on quality of life. The rates of those with food allergies
have notably increased in the past decade, suggesting that environmental factors are driving most of
the increase [1]. Numerous animal and human studies have supported this theory with the connection
of the gut microbiome. Alteration of the microbiota across The Big Eight allergies shows a consistent
unique signature involving the Firmicutes phylum. Interaction of the microbiome and microbial
metabolites (SCFAs) with host immune response is likely the mechanism by which the microbiome
affects food allergy. The addition of probiotics, both traditional (Lactobacillus and Bifidobacterium)
and next generation (Clostridia), along with other dietary interventions have shown significance
in helping prevent and treat disease. This knowledge may be used to develop products utilizing
these as functional additives. Further research must be conducted to identify potential differences in
mechanisms, prevention, and treatment between different antigens.
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